HM90822
HM90822 is an orally active IAP antagonist. HM90822 induces ubiquitination and proteasome-dependent degradation of XIAP, cIAP1 and cIAP2 in sensitive pancreatic cancer cells. HM90822 induces Apoptotic cell death. HM90822 inhibits tumor growth in Panc-1 pancreatic cancer xenograft and orthotopic mouse models. HM90822 can be used for the research of pancreatic cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1363145-46-3
- Formule: C30H36ClF2N7O4
- Masse moléculaire:632.11
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
XIAP |
cIAP-1 |
cIAP2 |
HM90822 (72 h) induces dose-dependent cell death in human pancreatic cancer cell lines, with IC50 values of 0.142 μM (BxPC-3), 0.164 μM (Panc03.27), 0.324 μM (Panc-1), 5.3 μM (PL45), and 6.7 μM (Capan-1) after 72 h incubation, while Panc08.13, MiaPaCa-2, Capan-2, and AsPC-1 cells are resistant with IC50 values above 37 μM[1].
HM90822 (0.3-10 μM; 18 h) induces dose-dependent reduction of XIAP and cIAP1 protein expression in sensitive BxPC-3 and Panc-1 human pancreatic cancer cell lines after 18 h incubation, but has no effect on these proteins in resistant MiaPaCa-2 and Capan-2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
HM90822 (50-200 mg/kg; p.o.; once daily; for 14 consecutive days) exerts anti-tumor effects in female Balb/c nude mice with Panc-1 orthotopic xenografts[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Balb/c nude (female)[1]
-
Dosage:150 mg/kg
-
Administration:p.o.; daily; 14 days
-
Result:Reduced tumor size compared to controls.
Did not alter body weight compared to controls.
-
Animal Model:Balb/c nude (female)[1]
-
Dosage:50 mg/kg; 100 mg/kg; 200 mg/kg
-
Administration:p.o.; daily; 14 days
-
Result:Significantly reduced intrapancreatic tumor weight at all tested doses compared to controls (P<0.05).
Reduced body weights by approximately 10-20% compared to controls.
Chemical Information
-
CAS No. 1363145-46-3
-
Masse moléculaire 632.11
-
Formule C30H36ClF2N7O4
-
SMILES
N(C=1C2=C(C=C(OC)C(NC(=O)[C@H]3N(C([C@@H](NC([C@@H](NC)C)=O)[C@](C)(C)C)=O)CCC3)=C2)N=CN1)C4=C(F)C(Cl)=C(F)C=C4
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
HM90822 Related Classifications
HY-12440 Related Classifications
Powered by Bioz